Fluticasone furoate with vilanterol (brand name Breo Ellipta) is an inhaled combination preventer medicine for people with asthma that cannot be controlled with low-dose combination preventer treatments. It is for people needing a medium- or high-dose corticosteroid with long-acting beta-2-receptor agonist.
When it comes to new medicines that are relevant to your condition, how do you decide if 'new' is 'better'? Medicine Update helps you to answer this question as new medicines become available.
Each issue includes an independent assessment of current information and research about a different medicine.
Find out more about Medicine Update.
- reliable, up-to-date information on health issues
- articles to help you make decisions about medicines and medical tests
- links to our resources and tools for managing your health
- the answer to one of the most commonly asked Medicinewise questions.